70.25USD+1.04%Mkt Cap: 7.55B USDP/E: 200.97Last update: 2026-06-01
Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap7.55B USD
Enterprise Value7.13B USD
Revenue (TTM)769.10M USD
Gross Profit748.43M USD
Net Income (TTM)99.65M USD
Revenue/Share7.399 USD
Last Price70.25 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees730
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)200.97
P/E (Forward)27.85
PEG0.81
EV/EBITDA-1028.31
EV/Revenue9.27
P/S9.70
P/B11.69
EPS (TTM)0.35
EPS (Forward)2.50
52W Range
28.6667% of range91.00
52W High91.00 USD
52W Low28.66 USD
Profitability
Gross Margin98.30%
Oper. Margin-30.08%
EBITDA Margin-0.90%
Profit Margin13.09%
ROE15.38%
ROA11.91%
Growth
Revenue Growth4.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF142.00M USD
CapEx (TTM)211.00K USD
FCF Margin15.04%
FCF Yield1.53%
Net Debt-328.55M USD
Net Debt/EBITDA47.38
Balance Sheet
Debt/Equity0.01
Current Ratio2.86
Quick Ratio2.53
Book Value/Sh5.944 USD
Cash/Share3.150 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)88.00 USD
Target Range50.00 USD – 135.00 USD
# Analysts5
Ownership
Shares Out.107.35M
Float88.98M
Insiders11.54%
Institutions75.75%
Short Interest
Short Ratio7.7d
Short % Float11.20%
Short % Out.8.68%
Shares Short9.32M
Short (prev mo.)11.34M
Technical
SMA 5047.31 (+48.5%)
SMA 20059.50 (+18.1%)
Beta0.35
S&P 52W Chg27.94%
Avg Vol (30d)1.08M
Avg Vol (10d)1.14M
Technical Indicators
RSI (14)82.7
MACD5.4280
MACD Signal4.3356
MACD Hist.+1.0923
BB Upper69.07 USD
BB Middle57.08 USD
BB Lower45.10 USD
BB Width41.99%
ATR (14)2.675 USD
Vol Ratio (20d)0.29x